| Glucotrack, Inc. |
Director, 10%+ Owner |
Common Stock, par value $0.001 per share |
2,743,591 |
$85,051,321 |
$31.00 |
12 Mar 2025 |
John A. Ballantyne Rev Trust 08/01/2017 |
| Glucotrack, Inc. |
Director, 10%+ Owner |
Common Stock, par value $0.001 per share |
4,126 |
$127,906 |
$31.00 |
26 Mar 2025 |
Direct |
| Glucotrack, Inc. |
Director, 10%+ Owner |
Series A Common Warrant |
132,036 |
|
|
14 Nov 2024 |
John A. Ballantyne Rev Trust 08/01/2017 |
| Glucotrack, Inc. |
Director, 10%+ Owner |
Warrants to Purchase Common Stock |
59,260 |
|
|
30 Jul 2024 |
John A. Ballantyne Rev Trust 08/01/2017 |
| Glucotrack, Inc. |
Director, 10%+ Owner |
Series B Common Warrant |
0 |
|
|
12 Mar 2025 |
John A. Ballantyne Rev Trust 08/01/2017 |